Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=30046747
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Managing thrombosis in cancer patients
#MMPMID30046747
Wang TF
; Li A
; Garcia D
Res Pract Thromb Haemost
2018[Jul]; 2
(3
): 429-438
PMID30046747
show ga
Venous thromboembolism is a major complication in cancer patients. The basis for
the strong association between cancer and thrombosis remains incompletely
understood, and the optimal approaches to both the treatment and the prevention
of cancer-associated thrombosis are evolving. Here we review several important
topics related to cancer-associated thromboembolism, including the pathogenesis,
prevention, and management of this disease. Wherever possible, we include
evidence from clinical trials, including the results of recently published trials
that compared direct oral anticoagulants to low-molecular-weight heparin for the
treatment of cancer-associated thrombosis.